Medline Inc.
Medline Inc. (Nasdaq: MDLN) provides medical-surgical products and supply chain services to healthcare customers across hospitals, surgery centers, physician offices and post-acute facilities. Its offerings include surgical and procedural kits, gloves and protective apparel, wound care, urological and incontinence… From the company’s description.
In fiscal 2025, Medline Inc. reported revenue of $28.43B. Its operating margin was 7.8%, and operations generated $1.74B in cash.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure.
What Medline Inc. does
In the company’s own words
Medline Inc. (Nasdaq: MDLN) provides medical-surgical products and supply chain services to healthcare customers across hospitals, surgery centers, physician offices and post-acute facilities. Its offerings include surgical and procedural kits, gloves and protective apparel, wound care, urological and incontinence care, and laboratory and diagnostic products, as well as consulting, warehouse and technology management, logistics and inventory services. Medline operates two reportable segments: Medline Brand, which offers about 190,000 products, and Supply Chain Solutions, which offers about 145,000 products from more than 1,300 third-party suppliers. The company manufactures about one-third of its Medline Brand products and distributes products through a global network of 70 facilities and its U.S. MedTrans truck fleet. As of December 31, 2025, Medline employed more than 45,000 people worldwide. Its brands include Medline, Curad, Microtek, Hudson and Proxima. Founded in 1966, the company operates through Medline Holdings, LP and its subsidiaries.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- NORTHFIELD, IL
- Fiscal year end
- December
- CIK
- 2046386
- SIC
- 3841
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Medline Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Medline Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Medline Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Medline Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Medline Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Medline Inc.'s last four quarterly filings that the numbers alone won't show?”
